Showing results (11-20 of 185) with videos related to
Sort By:
Pageof 19
Swiss Medical Weekly|March 23, 2018
New insights into the pathophysiology of inflammatory bowel disease: microbiota, epigenetics and common signalling pathwaysGerhard Rogler, Luc Biedermann, Michael ScharlDigestive Diseases (Basel, Switzerland)|February 2, 2017
Anti-Cytokine Strategies beyond Anti-Tumour Necrosis Factor-α Therapy: Pathophysiology and Clinical ImplicationsGerhard Rogler, Luc Biedermann, Michael ScharlClinical and Translational Gastroenterology|July 14, 2017
Fistulizing Crohn's DiseaseMichael Scharl, Gerhard Rogler, Luc BiedermannVisceral Medicine|April 8, 2024
Microbiota Therapy in Inflammatory Bowel DiseaseLuc Biedermann, Andrea Kreienbühl, Gerhard RoglerDigestive Diseases (Basel, Switzerland)|September 15, 2015
Integrating Imaging into Clinical Practice in Inflammatory Bowel DiseaseGerhard Rogler, Stephan R Vavricka, Luc BiedermannDigestive Diseases (Basel, Switzerland)|March 17, 2016
High Altitude Journeys, Flights and Hypoxia: Any Role for Disease Flares in IBD Patients?Stephan R Vavricka, Gerhard Rogler, Luc BiedermannSeminars in Immunopathology|June 7, 2021
Eosinophilic esophagitis-established facts and new horizonsLuc Biedermann, Alex Straumann, Thomas Greuter, et al.Inflammatory Intestinal Diseases|July 19, 2018
The Efficacy and Safety of Golimumab as Third- or Fourth-Line Anti-TNF Therapy in Patients with Refractory Crohn's Disease: A Case SeriesLinda Russi, Michael Scharl, Gerhard Rogler, et al.BMJ Case Reports|January 12, 2021
Protein-losing enteropathy as precursor of inflammatory bowel disease: a review of the literatureFritz Ruprecht Murray, Bernhard Morell, Luc Biedermann, et al.Pageof 19